# Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer

> **NCT04158349** · PHASE1 · TERMINATED · sponsor: **University of Utah** · enrollment: 1 (actual)

## Conditions studied

- Colorectal Cancer
- Appendiceal Cancer
- Peritoneal Carcinoma

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** mFOLFIRI

## Key facts

- **NCT ID:** NCT04158349
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-22
- **Primary completion:** 2021-05-14
- **Final completion:** 2021-05-14
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** PI Decision
- **Last updated:** 2021-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04158349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04158349, "Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04158349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*